Because Ned Said: Drug Shortage or Not, That Is the Question

In his latest article for Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, examined what it means for patients and pharmacies when regulators declare an end to a drug shortage. He explores the many factors behind drug shortages, from manufacturing and supply chain disruption to market forces, as well as how regulators, pharmacists, and other stakeholders can work together to accurately identify and assess them.